This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!
Press and hold the button
If you believe this is an error, please contact our support team.
192.64.82.12 : 9adbd795-7b06-4a8c-a7f3-e52b73df
Associations of disease risk with change in body mass index (BMI) or glycated haemoglobin (HbA1c). Credit: Diabetes, Obesity and Metabolism (2024). DOI:10.1111/dom.15896 A Cleveland Clinic research team has published the
Credit: Pharmacological Research (2024). DOI: 10.1016/j.phrs.2024.107428 Therapies that deliver hydrogen sulfide to cells could one day become the basis of new treatments for obesity and related diseases, new research has
Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves symptoms in men and women with a common type of heart failure that has had few therapeutic
